- US12128071utility2024Method of Treating Illness Using Lyophilized Camel Urine0 cites
- US12128381utility2024Microporous Thin Film0 cites
- US12128390utility2024Tri-metallic Organic Framework (MOF) Complex as a Reduction Catalyst0 cites
- US12129252utility2024Pyrrolo[2,3-c][2,6]naphthyridine-8-carboxylic Acids as CK2 Inhibitors0 cites
- US12129254utility2024Pyrimido[6′,1′:2,3]imidazo[4,5-b][1,6]naphthyridine Compounds as CK2 Inhibitors0 cites
- US12129257utility2024Imidazo[1,2-a]pyrazine Compounds as CK2 Inhibitors0 cites
- US12129259utility2024Pyrazino[1′,2′:1,5]pyrazolo[4,3-b][1,6]naphthyridines Compounds as CK2 Inhibitors0 cites
- US12129260utility2024Benzofuro[3,2-c]chromen-6-one Compounds as Antibacterial Agents0 cites
- US12121548utility2024Method for Synthesizing a Silver Nanoparticle Composition from Rhynchophorus Ferrugineus Larvae Olivier0 cites
- US12121555utility2024Method for Inhibiting Enzyme Activity Using Boscia Senegalensis0 cites
- US12121561utility2024Composition for Treating or Preventing Insulin Resistance0 cites
- US12122752utility20245-(2,4,5-tris(4-chlorophenyl)-1h-imidazol-1-yl)pentanoic Acid as an Antimicrobial Compound0 cites
- US12122770utility20242-(benzo[d]oxazol-2-yl)-n'-(nicotinoyloxy)acetimidamide as an Antimicrobial Compound0 cites
- US12122775utility2024Substituted Pyrido[4,3-e]pyrrolo[1,2-a]pyrazines as CK2 Inhibitors0 cites
- US12123102utility2024Highly Textured PEPD Tenorite Film on Steel and Method of Making the Same0 cites
- US12115201utility2024Method for Synthesizing Silver Nanoparticles from Amaranthus Hybridus0 cites
- US12115202utility2024Method of Preventing Cadmium-induced Liver Toxicity Using a Plant Product Derived from Achillea Millefolium L0 cites